Caleb Moore

Caleb Moore is Vice President, Portfolio Strategy & Business Operations at CAMP4 Therapeutics. He is responsible for guiding CAMP4’s disease selection and program strategy based on biological rationale and downstream development and commercial considerations. He also oversees CAMP4’s operational activities, including laboratory operations, IT, and space planning.

Prior to joining CAMP4, Mr. Moore was Senior Director of Corporate Development at Acceleron Pharma, where he helped translate the company’s expertise in TGFβ biology into a focused therapeutic area strategy. He was instrumental in establishing Pulmonary as a pillar of Acceleron’s strategy based on the disease-modifying potential of its lead program in pulmonary arterial hypertension (PAH). Prior to Acceleron, Mr. Moore worked in Global New Product Planning at Cubist Pharmaceuticals, defining early commercial strategy for internal programs and external opportunities. He also held positions in Business Development & Strategy at Genzyme, steering multiple transactions that contributed to the growth of the rare disease and cardio-metabolic/renal businesses. Mr. Moore began his life sciences career at a boutique consulting and market research firm.

Mr. Moore earned a BA in Genetics, Cell & Developmental Biology from Dartmouth College and holds an MBA from the Tuck School of Business at Dartmouth.